Logo image of VTRS

VIATRIS INC (VTRS) Stock Fundamental Analysis

USA - NASDAQ:VTRS - US92556V1061 - Common Stock

10.31 USD
+0.14 (+1.38%)
Last: 10/20/2025, 8:21:27 PM
10.4 USD
+0.09 (+0.87%)
After Hours: 10/20/2025, 8:21:27 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to VTRS. VTRS was compared to 191 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of VTRS while its profitability can be described as average. VTRS has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year VTRS was profitable.
In the past year VTRS had a positive cash flow from operations.
In multiple years VTRS reported negative net income over the last 5 years.
Each year in the past 5 years VTRS had a positive operating cash flow.
VTRS Yearly Net Income VS EBIT VS OCF VS FCFVTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

VTRS has a Return On Assets of -9.03%. This is in the better half of the industry: VTRS outperforms 67.02% of its industry peers.
VTRS has a Return On Equity of -22.27%. This is in the better half of the industry: VTRS outperforms 65.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.61%, VTRS belongs to the top of the industry, outperforming 80.63% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for VTRS is significantly below the industry average of 15.45%.
Industry RankSector Rank
ROA -9.03%
ROE -22.27%
ROIC 3.61%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
VTRS Yearly ROA, ROE, ROICVTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

With an excellent Operating Margin value of 10.13%, VTRS belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
In the last couple of years the Operating Margin of VTRS has declined.
VTRS's Gross Margin of 40.15% is fine compared to the rest of the industry. VTRS outperforms 61.78% of its industry peers.
In the last couple of years the Gross Margin of VTRS has remained more or less at the same level.
Industry RankSector Rank
OM 10.13%
PM (TTM) N/A
GM 40.15%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
VTRS Yearly Profit, Operating, Gross MarginsVTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VTRS is destroying value.
VTRS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for VTRS has been increased compared to 5 years ago.
VTRS has a better debt/assets ratio than last year.
VTRS Yearly Shares OutstandingVTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VTRS Yearly Total Debt VS Total AssetsVTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 0.89, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VTRS (0.89) is comparable to the rest of the industry.
VTRS has a debt to FCF ratio of 7.49. This is a slightly negative value and a sign of low solvency as VTRS would need 7.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.49, VTRS is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
VTRS has a worse Debt to Equity ratio (0.82) than 71.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 7.49
Altman-Z 0.89
ROIC/WACC0.49
WACC7.44%
VTRS Yearly LT Debt VS Equity VS FCFVTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.37 indicates that VTRS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.37, VTRS is doing worse than 72.25% of the companies in the same industry.
VTRS has a Quick Ratio of 1.37. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.77, VTRS is doing worse than 82.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.77
VTRS Yearly Current Assets VS Current LiabilitesVTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

The earnings per share for VTRS have decreased strongly by -13.00% in the last year.
Measured over the past years, VTRS shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.73% on average per year.
VTRS shows a decrease in Revenue. In the last year, the revenue decreased by -7.37%.
Measured over the past years, VTRS shows a small growth in Revenue. The Revenue has been growing by 5.09% on average per year.
EPS 1Y (TTM)-13%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.14%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%-5.65%

3.2 Future

VTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.64% yearly.
The Revenue is expected to grow by 0.09% on average over the next years.
EPS Next Y-12.16%
EPS Next 2Y-3.01%
EPS Next 3Y0.91%
EPS Next 5Y2.64%
Revenue Next Year-6.25%
Revenue Next 2Y-2.36%
Revenue Next 3Y-1.08%
Revenue Next 5Y0.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VTRS Yearly Revenue VS EstimatesVTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
VTRS Yearly EPS VS EstimatesVTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.28, which indicates a rather cheap valuation of VTRS.
Based on the Price/Earnings ratio, VTRS is valued cheaply inside the industry as 97.38% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.69, VTRS is valued rather cheaply.
VTRS is valuated cheaply with a Price/Forward Earnings ratio of 4.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 96.86% of the companies listed in the same industry.
VTRS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.18.
Industry RankSector Rank
PE 4.28
Fwd PE 4.14
VTRS Price Earnings VS Forward Price EarningsVTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 96.86% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, VTRS is valued cheaper than 93.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.04
EV/EBITDA 5.7
VTRS Per share dataVTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.01%
EPS Next 3Y0.91%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.75%, VTRS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.88, VTRS pays a better dividend. On top of this VTRS pays more dividend than 97.38% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, VTRS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.75%

5.2 History

VTRS has paid a dividend for at least 10 years, which is a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
VTRS Yearly Dividends per shareVTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-16.42%
EPS Next 2Y-3.01%
EPS Next 3Y0.91%
VTRS Yearly Income VS Free CF VS DividendVTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

VIATRIS INC

NASDAQ:VTRS (10/20/2025, 8:21:27 PM)

After market: 10.4 +0.09 (+0.87%)

10.31

+0.14 (+1.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners85.59%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change1.07%
Market Cap12.02B
Analysts54.29
Price Target11.26 (9.21%)
Short Float %3.59%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield 4.75%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-16.42%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-22 2025-08-22 (0.12)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.75%
Min EPS beat(2)0.14%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.74%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)0.86%
EPS beat(12)7
Avg EPS beat(12)1.16%
EPS beat(16)10
Avg EPS beat(16)2.05%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-1.38%
Max Revenue beat(2)1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)1.3%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)1
Avg Revenue beat(12)-2.35%
Revenue beat(16)2
Avg Revenue beat(16)-2.22%
PT rev (1m)0%
PT rev (3m)3.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.27%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)3.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE 4.28
Fwd PE 4.14
P/S 0.85
P/FCF 7.04
P/OCF 5.82
P/B 0.77
P/tB N/A
EV/EBITDA 5.7
EPS(TTM)2.41
EY23.38%
EPS(NY)2.49
Fwd EY24.18%
FCF(TTM)1.46
FCFY14.2%
OCF(TTM)1.77
OCFY17.17%
SpS12.11
BVpS13.36
TBVpS-6.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.03%
ROE -22.27%
ROCE 4.57%
ROIC 3.61%
ROICexc 3.69%
ROICexgc 14.98%
OM 10.13%
PM (TTM) N/A
GM 40.15%
FCFM 12.1%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexcg growth 3Y-9.04%
ROICexcg growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 7.49
Debt/EBITDA 3.05
Cap/Depr 12.94%
Cap/Sales 2.53%
Interest Coverage 250
Cash Conversion 49.28%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.77
Altman-Z 0.89
F-Score4
WACC7.44%
ROIC/WACC0.49
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.14%
EPS Next Y-12.16%
EPS Next 2Y-3.01%
EPS Next 3Y0.91%
EPS Next 5Y2.64%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%-5.65%
Revenue Next Year-6.25%
Revenue Next 2Y-2.36%
Revenue Next 3Y-1.08%
Revenue Next 5Y0.09%
EBIT growth 1Y1.9%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.71%
EBIT Next 3Y0.26%
EBIT Next 5Y0.47%
FCF growth 1Y-16.49%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-17.35%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%